Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Courses

ESMO Advanced Course on Early Drug Development 2024: Hong Kong SAR

02 - 04 Feb 2024

Hong Kong SAR, China

ESMO-Advanced-Courses-Early-Drug-Development-1000x1000

Slides and Webcasts from all ESMO Advanced Courses are reserved to ESMO Members and registered participants, according to the presenters' agreement to release them. ESMO thanks the authors for their generosity.

The copyright protected educational resources from this event are for personal usage only and not to be shared with any third parties.

Meeting programme Next/upcoming meetings
Learning Objectives
  • To foster, educate and mentor the next generation of Phase I/Early Drug Development Programmes in Oncology centres from both the established and emerging economies in the Asia-Pacific region.
  • To understand the fundamentals to establishing and running a successful Phase I/Early Drug Development Programme: from an in-depth understanding of trial selection to patient coordination, to running a programme, to effectively engaging with sponsors and fellow PIs, regional and international engagement, regulatory processes. 
  • To bridge the gap between the key stakeholders in the drug development process in the Asia-Pacific region: investigators, sponsors (Pharma and Biotech), Contract Research Organization (CRO), regulatory bodies.

This event has been supported by an unrestricted educational grant from AstraZeneca, BeiGene, IQVIA and Roche.

Hide
Filter by:
Search:
Reset

There are 15 resources available

Welcome and Introduction

Presenter: Jayesh Desai, AU Elena Garralda, ES and Brigette Ma, HKSAR CN

Session: Welcome and introduction

Resources:

Slides

Webcast

The Academic perspective

Presenter: Brigette Ma, HKSAR CN

Session: Session 4 - The Academia and the Industry Perspective: Strenghts and challenges in bringing Phase I studies to region

Resources:

Slides

Webcast

The Industry perspective

Presenter: Ezogelin Gruyters, US

Session: Session 4 - The Academia and the Industry Perspective: Strenghts and challenges in bringing Phase I studies to region

Resources:

Slides

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.